Predicting Unilateral Prostate Cancer Based On Biopsy Features: Implications For Focal Ablative Therapy Results From The SEARCH Database
Main Category: Prostate / Prostate CancerAlso Included In: Men's health; Urology / Nephrology; Clinical Trials / Drug Trials
Article Date: 28 Oct 2007 - 0:00 PDT
| Patient / Public: | ![]() |
3.67 (3 votes) |
| Healthcare Prof: | ![]() |
UroToday.com- New focal ablative therapies that just treat areas of the prostate containing tumor are being reported. However, according to a report in the October, 2007 issue of the Journal of Urology from the SEARCH Database, unilateral prostate cancer (CaP) can not be identified preoperatively by biopsy criteria.
The SEARCH database is comprised of a multicenter Veterans Affairs dataset of patients with CaP. The authors identified 261 men with clinical stage T1c or T2 CaP, PSA <10ng/ml, Gleason score <6, and 1 or 2 ipsilateral positive cores on at least sextant biopsy.
Mean patients age was 60.6 years and 55% were white and 38% were black. Median PSA was 5.5ng/ml and the median number of biopsy cores obtained was 8. Only 93 of the 261 men (35%) had unilateral disease on examination of the radical prostatectomy specimen. This means about two-thirds of patients with unilateral low risk CaP on biopsy had bilateral CaP on pathological examination of the surgical specimen. Age did not predict for unilateral vs. bilateral CaP. In multivariable analysis no preoperative clinical factors were predictive of unilateral vs. bilateral disease. This suggests that focal therapies can not be adequately planned upon the assumption that only unilateral disease exists in most patients. The clinical implications for focal therapies, however, are not know from this data but the suggestion is that complete tumor ablation will not be achieved.
Scales CD, Presti JC, Kane CJ, Terris MK, Aronson WJ, Amling CL, Freedland SJ for the SEARCH Database Study Group
J Urol. ePub: August 15, 2007
doi:10.1016/j.juro.2007.05.151
Reported by UroToday.com Contributing Editor Christopher P. Evans, M.D
UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice.
To access the latest urology news releases from UroToday, go to: www.urotoday.com
----------------------------
Copyright © 2007 - UroToday
Reproduced for Medical News Today with permission of UroToday.
----------------------------
Visit our prostate / prostate cancer section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/86899.php>
APA
http://www.medicalnewstoday.com/releases/86899.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




